Recurrence pattern after [(18)F]Fluoroethyltyrosine-Positron Emission Tomography-guided radiotherapy for high-grade glioma: A prospective study

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 586-592

  Weber, Damien C ^a,c   Casanova, Nathalie ^a   Zilli, Thomas ^a   Buchegger, Franz ^b   Rouzaud, Michel ^a   Nouet, Philippe ^a   Vees, Hansjorg ^a   Ratib, Osman ^b,c   Dipasquale, Giovanna ^a   Miralbell, Raymond ^a,c  

^a Department of Radiation Oncology ^*  (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

FET PET; Glioblastoma; Recurrence pattern

Indexed keywords

BEVACIZUMAB; FLUOROETHYLTYROSINE F 18; IRINOTECAN; OXALIPLATIN; RADIOPHARMACEUTICAL AGENT; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOMA; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TREATMENT FAILURE; TUMOR VOLUME;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 70449846696     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.043     Document Type: Article

References (20)

1. Kato T., Shinoda J., Nakayama N., et al. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. Ajnr 29 (2008) 1176-1182
2. Estrada G., Gonzalez-Maya L., Celis-Lopez M.A., et al. Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico. Rev Esp Med Nucl 27 (2008) 329-339
3. Floeth F.W., Pauleit D., Sabel M., et al. Prognostic value of O-(2-18F-fluoroethyl)-l-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48 (2007) 519-527
4. Pirotte B.J., Levivier M., Goldman S., et al. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery 64 (2009) 471-481 discussion 481
5. Charnley N., West C.M., Barnett C.M., et al. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 331-338
6. Miwa K., Matsuo M., Shinoda J., et al. Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with (11)C-methionine PET: report of three cases. J Neurooncol (2008) [Epub ahead of print]
7. Mahasittiwat P., Mizoe J.E., Hasegawa A., et al. l-[Methyl-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 515-522
8. Grosu A.-L., Weber W.A., Riedel E., et al. l-(Methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 64-74
9. Lee I.H., Piert M., Gomez-Hassan D., et al. Association of (11)C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008)
10. Weber D.C., Zilli T., Buchegger F., et al. [(18)F]Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma. Radiat Oncol (London, UK) 3 (2008) 44
11. Vees H., Senthamizhchelvan S., Miralbell R., Weber D.C., Ratib O., and Zaidi H. Assessment of various strategies for (18)F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging (2008)
12. Chang E.L., Akyurek S., Avalos T., et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 68 (2007) 144-150
13. Chan J.L., Lee S.W., Fraass B.A., et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20 (2002) 1635-1642
14. Hess C.F., Schaaf J.C., Kortmann R.D., Schabet M., and Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30 (1994) 146-149
15. Oppitz U., Maessen D., Zunterer H., Richter S., and Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 53 (1999) 53-57
16. Wick W., Stupp R., Beule A.C., et al. A novel tool to analyse MRI recurrence patterns in glioblastoma. Neuro-oncol (2008)
17. Mangiola A., de Bonis P., Maira G., et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 113 (2008) 841-846
18. Schiffer D., Cavalla P., Dutto A., and Borsotti L. Cell proliferation and invasion in malignant gliomas. Anticancer Res 17 (1997) 61-69
19. Berens M.E., and Giese A. "...those left behind" Biology and oncology of invasive glioma cells. Neoplasia (New York, NY) 1 (1999) 208-219
20. Cattaneo G.M., Reni M., Rizzo G., et al. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiother Oncol 75 (2005) 217-223